Zonisamide was used as an add-on drug in 25 non-obese patients with drug resistant epilepsy. After 3-month follow-up patients had seizures' reduction and the body weight was apparently unchanged. We also found a decrease of the anxiety levels and an increase of Quality of Life values. Our data are preliminary; we have to complete our protocol to confirm these findings.
Zonisamide: body weight and behavioral aspects = Zonisamide, peso corporeo e aspetti comportamentali / A. Piazzini, K. Turner, V. Chiesa, A. Vignoli, E. Gardella, F. La Briola, R. Canger, M.P. Canevini. - In: BOLLETTINO-LEGA ITALIANA CONTRO L'EPILESSIA. - ISSN 0394-560X. - 140:(2010 Apr), pp. 191-194. ((Intervento presentato al 32. convegno Congresso LICE tenutosi a Sorrento nel 2010.
Zonisamide: body weight and behavioral aspects = Zonisamide, peso corporeo e aspetti comportamentali
A. Vignoli;R. CangerPenultimo
;M.P. CaneviniUltimo
2010
Abstract
Zonisamide was used as an add-on drug in 25 non-obese patients with drug resistant epilepsy. After 3-month follow-up patients had seizures' reduction and the body weight was apparently unchanged. We also found a decrease of the anxiety levels and an increase of Quality of Life values. Our data are preliminary; we have to complete our protocol to confirm these findings.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
